
National Grand Rounds - October 2025
Includes a Live Web Event on 10/07/2025 at 12:00 PM (EDT)
-
Register
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
Gadolinium Deposition Disease
Join ACMT on Tuesday, October 7, 2025, at 12 PM ET for an exclusive National Grand Rounds featuring Dr. Brent Wagner. A leading expert in nephrogenic systemic fibrosis and gadolinium retention, Dr. Wagner will share insights from his groundbreaking research on Gadolinium Deposition Disease, a condition linked to the use of MRI contrast agents in patients with impaired renal function. This session will explore the clinical implications, pathophysiology, and evolving understanding of gadolinium-related complications.
About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.
This webinar is for ACMT members only.

Brent Wagner, MD, MS
Associate Professor of Nephrology
University of New Mexico Health Science Center
Dr. Brent Wagner is a board-certified specialist in Internal Medicine and Nephrology, with a distinguished career in clinical care, research, and medical education. A native of New Mexico, he earned his undergraduate, graduate, and medical degrees from the University of New Mexico, and completed his residency on the ABIM Research Investigator Pathway at the University of Texas Health System. He previously served as Clinical Nephrology Fellowship Program Director and staff nephrologist at the Audie Murphy Memorial VA Hospital, and became a tenured Associate Professor in 2017. In 2018, he returned to Albuquerque to lead the Renal Section at the New Mexico VA Health Care System and direct the Kidney Institute of New Mexico. An internationally recognized expert in nephrogenic systemic fibrosis, gadolinium retention, and nanotoxicology, Dr. Wagner’s pioneering research has advanced understanding of the molecular and cellular effects of MRI contrast agents.

Nicholas E. Nacca, MD, FACMT (Moderator)
Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Fellowship Director of Medical Toxicology Fellowship Program
University of Rochester Medical Center
Dr. Nicholas Nacca is the director of Medical Toxicology and Medical Toxicology Fellowship Director at the University of Rochester Medical Center. In addition to being faculty member in the Department of Emergency Medicine he holds a secondary appointment in the Department of Environmental Medicine. His primary role is staffing the educational and clinical medical toxicology consultation service, with educational responsibilities to medical toxicology fellows, multidisciplinary teams of medical residents, pharmacy residents and students, as well as medical students. He staffs and directs a referral based outpatient Medical Toxicology Clinic.
Key:




